Halberd Corp. Issues Letter to Shareholders – Patented LDN+ Evolves into WatchDawg™ for Veteran Suicide Reduction
Early Pilot Study Data from Veteran Volunteers is Compelling Jackson Center, PA September 4, 2024 – PRISM MediaWire – Halberd Corporation (OTC: HALB) To our shareholders: As promised, this is the second of three Press Releases on our recent progress. If you have not had a chance to review that last one, on the good […]
Halberd Corp. Issues Letter to Shareholders
JACKSON CENTER, Pa., Aug. 26, 2024 (GLOBE NEWSWIRE) — Halberd Corporation (OTC PINK: HALB) today issued the following letter to its shareholders: Halberd Corp. – Taking a Moment to Recenter Our Technical Progress Introducing Tri-ax™ TBI Nasal Spray Treatment– the DoD selected our MSU-led pre-proposal, inviting us to submit a full application/proposal This is the first of […]
Halberd Corp’s (OTC: HALB) Groundbreaking Traumatic Brain Injury (TBI) Mitigation Nasal Spray Shows Promising Phase II Initial Test Results
Jackson Center, PA July 24, 2024 – Halberd Corporation (OTC-PINK: “HALB”) has announced encouraging preliminary outcomes from its Phase II testing at Mississippi State University (MSU) of its Tri-AxTM nasal spray, aimed at mitigating the effects of traumatic brain injury (TBI) following head trauma. Dr. Russell Carr, the project’s Principal Investigator, commented: “In the early […]